LDL CHOLESTEROL LOWERING WITH PCSK9 INHIBITION AND PLAQUE VOLUME, CALF MUSCLE PERFUSION, AND WALKING PERFORMANCE IN PERIPHERAL ARTERIAL DISEASE

被引：0
|
作者：
Kaso, Elona Rrapo
Er, Adrian Ignacio Loffl
Petroni, Gina R.
Meyer, Craig
Walker, McCall R.
Carr, James C.
McDermott, Mary M.
Kramer, Christopher M.
机构：
[1] Univ Virginia Hlth Syst, Charlottesville, VA USA
[2] Northwestern Univ, Chicago, IL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
905-04
引用
收藏
页码：2011 / 2011
页数：1
相关论文
共 50 条
  • [1] Variation in PCSK9, low LDL cholesterol, and risk of peripheral arterial disease
    Folsom, Aaron R.
    Peacock, James M.
    Boerwinkle, Eric
    ATHEROSCLEROSIS, 2009, 202 (01) : 211 - 215
  • [2] PCSK9 inhibition for LDL lowering and beyond - implications for patients with peripheral artery disease
    Gebauer, Katrin
    Reinecke, Holger
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2018, 47 (03) : 165 - 176
  • [3] LDL Lowering Does Not Improve Calf Muscle Perfusion or Energetics or Exercise Performance in Peripheral Arterial Disease
    West, Amy M.
    Anderson, Justin D.
    Epstein, Frederick H.
    Meyer, Craig H.
    Hagspiel, Klaus D.
    Wang, Hongkun
    Berr, Stuart S.
    Harthun, Nancy L.
    Wellman, Arthur L.
    DiMaria, Joseph M.
    Hunter, Jennifer R.
    Christopher, John M.
    Kramer, Christopher M.
    CIRCULATION, 2009, 120 (18) : S1046 - S1046
  • [4] PCSK9 inhibition for acute arterial events: more than LDL lowering
    Orringer, Carl E.
    EUROPEAN HEART JOURNAL, 2021, 42 (47) : 4830 - 4832
  • [5] PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering
    Cariou, Bertrand
    Ding, Zufeng
    Mehta, Jawahar L.
    ATHEROSCLEROSIS, 2016, 253 : 275 - 277
  • [6] LDL LOWERING EFFECT OF PCSK9 INHIBITION IS REDUCED IN WOMEN
    Myasoedova, V.
    Rimbert, A.
    Camera, M.
    Le May, C.
    Capoulade, R.
    Cariou, B.
    Poggio, P.
    ATHEROSCLEROSIS, 2023, 379
  • [7] Key aspects of PCSK9 inhibition beyond LDL lowering
    Ramin-Mangata, Stephane
    Blanchard, Valentin
    Lambert, Gilles
    CURRENT OPINION IN LIPIDOLOGY, 2018, 29 (06) : 454 - 459
  • [8] LDL lowering effect of PCSK9 inhibition is reduced in women
    Myasoedova, Veronika A.
    Rimbert, Antoine
    Camera, Marina
    Le May, Cedric
    Capoulade, Romain
    Cariou, Bertrand
    Poggio, Paolo
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (04) : 337 - 342
  • [9] PCSK9, a novel target for lowering LDL cholesterol: promise and progress
    Tavori, Hagai
    Fazio, Sergio
    Linton, MacRae F.
    CLINICAL LIPIDOLOGY, 2012, 7 (06) : 611 - 615
  • [10] PCSK9 inhibition: the dawn of a new age in cholesterol lowering?
    David Preiss
    Marion Mafham
    Diabetologia, 2017, 60 : 381 - 389
12345